Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 May;21(2):169-81.
doi: 10.1023/a:1023521412787.

Use of positron emission tomography in anticancer drug development

Eric O Aboagye  1 , Patricia M Price
Affiliations
Review

Use of positron emission tomography in anticancer drug development

Eric O Aboagye et al. Invest New Drugs. 2003 May.

Abstract

Positron emission tomography (PET) is increasingly being used in anticancer drug development. The technique is applicable to studies of drug delivery, and where specific probes are available, to provide pharmacodynamic readouts noninvasively in patients. Mathematical modeling of the imaging data enhances the quality of information that is obtained from such studies. This section provides a review of the PET methodologies that have been used for the development of new cancer therapies. Other than imaging of radiolabeled drugs, PET modeling has found extensive application in studies with 2-[11C]thymidine, [18F]fluorodeoxyglucose, H2(15)O, C15O, and receptor ligands.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. N Engl J Med. 1977 Mar 3;296(9):486-92 - PubMed
    1. J Biol Chem. 1996 Dec 20;271(51):32529-37 - PubMed
    1. Cancer Res. 1997 Aug 15;57(16):3415-23 - PubMed
    1. J Cereb Blood Flow Metab. 1990 Sep;10(5):740-7 - PubMed
    1. J Clin Oncol. 1990 Nov;8(11):1868-73 - PubMed

Publication types

Substances

LinkOut - more resources